In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...